{"id":"W4410884998","doi":"10.1016/j.annonc.2025.05.011","title":"Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma Europe; Astellas Pharma; Bayer HealthCare; Bayer; Astellas Pharma US","keywords":"Medicine; Enzalutamide; Prostate cancer; Radium-223; Oncology; Internal medicine; Cancer; Radium; Urology; Radiochemistry; Bone metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002091022,0.000816714,0.001405609,0.0002219454,0.0001915504,0.0007734483,0.0004666025,0.0005898297,0.002198286],"category_scores_gemma":[0.001297564,0.000227172,0.001746622,0.0004626,0.0004370564,0.0003936951,0.000298735,0.001698004,0.0003076815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006899165,"about_ca_system_score_gemma":0.0007715362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001097007,"about_ca_topic_score_gemma":0.003126362,"domain_scores_codex":[0.9993149,0.0004562488,0.00003037356,0.00005647146,0.00007822771,0.00006373049],"domain_scores_gemma":[0.9993209,0.0001643135,0.0002343188,0.00005198235,0.00004056683,0.000187931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.886211,0.003505893,0.007778226,0.001768806,0.006480977,0.0001429885,0.0001133693,0.002901244,0.004095768,0.0002923691,0.00549469,0.08121471],"study_design_scores_gemma":[0.7460693,0.1601776,0.06759857,0.0004261782,0.01016376,0.0006354264,0.0001078378,0.002460946,0.001863783,0.0009127445,0.009512127,0.00007181099],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712062,0.02201742,0.0003531907,0.0008221792,0.0002251868,0.0004160596,0.001510838,0.00008356301,0.00336539],"genre_scores_gemma":[0.9885294,0.005858476,0.000507299,0.0007394784,0.0002533279,0.0003334759,0.002243643,0.0000257241,0.001509257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002198286,"threshold_uncertainty_score":0.01105851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1190364184841984,"score_gpt":0.4541410662425793,"score_spread":0.3351046477583809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}